by marketing | Oct 29, 2024 | Bursa Malaysia, News
PETALING JAYA: Earnings of healthcare companies in the second half of 2024 (2H24) are likely to come in as strong as posted in 1H24. Affin Hwang Investment Bank Research said healthcare companies under its coverage registered strong second quarter (2Q24)...
by Regine | Apr 19, 2024 | Bursa Malaysia, News
Bursa approves UMediC’s transfer to Main Market KUALA LUMPUR (April 18): Bursa Malaysia Securities Bhd has approved the transfer of UMediC Group Bhd’s listing status from the ACE Market to the Main Market, under the ‘health...
by Regine | Apr 17, 2024 | News
KUALA LUMPUR (April 17): Hong Leong Investment Bank (HLIB) has maintained its “buy” rating on UMediC Group Bhd (UMC) at 62.5 sen with an unchanged target price (TP) of 91 sen and said UMC’s expansion efforts post completion of its new facility aim to...
by Regine | Apr 4, 2024 | Bursa Malaysia, News
（吉隆坡3日讯）UMediC Group Bhd获得大马证券监督委员会（SC）批准，转至大马交易所主板上市。 艾芬黄氏投资银行今日代表UMediC宣布上述消息，指证监会批准了转板上市和由此产生的股权结构。这符合2007年资本市场和服务法令第214（1）条文及上市公司的土著股权要求。 该集团于2022年7月26日在创业板上市。 该集团在截至去年7月杪财年（2023财年）净赚1036万令吉，并录得4543万令吉营业额。 ...
by Regine | Feb 6, 2024 | News
(吉隆坡5日讯）马股成功摆脱传统的“元月厄运”，今年1月升高4%站上1513点水平，同时也连续4个月收高，分析员认为，负面消息已全面反映在股市，且在6大利好发力下，富时综合指数现阶段可延续上涨动力，年底企稳1550点不是梦。 今年1月综指喜气洋洋，丰隆投资银行零售研究主管吴俊声今日在报告指出，马股暌违6年后终再现元月效应升高4％，反观过去5及10年平均下跌2.4及1%。 ...
